You are currently viewing a new version of our website. To view the old version click .
Proceedings
  • Abstract
  • Open Access

15 November 2017

Investigation of Apoptotic Effects of Usnic Acid on Hepatocellular Carcinoma †

,
,
,
,
and
1
Medical Biology Department, Faculty of Medicine, Uludag University, Gorukle, Bursa 16059, Turkey
2
Medical Biology Department, Faculty of Medicine, Sakarya University, Sakarya 54050, Turkey
*
Author to whom correspondence should be addressed.
Presented at the 2nd International Conference on Natural Products for Cancer Prevention and Therapy, Kayseri, Turkey, 8–11 November 2017.
This article belongs to the Proceedings Proceedings of the 2nd International Conference on Natural Products for Cancer Prevention and Therapy

Abstract

Hepatocellular carcinoma (HCC) ranks the sixth among common cancers in the world due to limited treatment option. In recent years, fungicides and lichen metabolites have gained importance in development of new generation chemotherapeutics. For this purpose, we aimed to investigate the cytotoxic and apoptotic effects of a lichen metabolite, usnic acid (UA), on HCC cells in the present study. After treatment with different concentrations (6.25–100 µM) of UA for 48 h, a significant decrease in the number of viable cells was determined in HCC cells. The HepG2 and SNU-449 cell viability decreased to 21.8% and 15.6% at the maximum concentration, respectively (p < 0.05). However cell viability ratio was 104.3% in HUVEC cells. Additionally, UA induced particularly late apoptosis in HCC cells in a dose-dependent manner. The percentage of apoptotic cells was significantly increased to 86.67% and 81.36% at 100 µM UA in HepG2 and SNU-449 cells, respectively. To confirm the apoptosis-inducing effect of UA, cells were stained with AO/EB and the morphological characteristic of apoptotic cell death were observed. In conclusion, UA displayed cytotoxic and apoptotic activity against human HCC cells without damaging control cells. Thus, we think that UA may be a suitable candidate as therapeutic agent for treatment of HCC.

Acknowledgments

We thank to Mehmet Ozturk from Dokuz Eylul University, Faculty of Medicine, Basic Medical Sciences Department of Medical Biology, who kindly provided hepatocellular carcinoma cell lines for the study.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.